Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Plos One|March 8, 2013
International multispecialty consensus on how to evaluate ultrasound competence: a Delphi consensus surveyMartin G Tolsgaard, Tobias Todsen, Jette L Sorensen, et al.Ultrasonography (Seoul, Korea)|June 20, 2023
Ablation therapy for patients with colorectal liver metastases with and without extrahepatic metastases: evaluation of long-term outcomes and prognostic factorsJeanett Klubien, Jacob Rosenberg, Bjørn Ole Skjoldbye, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|December 13, 2017
Use of Ultrasound Contrast Agents in Relation to Percutaneous Interventional Procedures: A Systematic Review and Pictorial EssayChristian Pállson Nolsøe, Alexander Bjørneboe Nolsøe, Jeanett Klubien, et al.Ultrasound in Medicine & Biology|September 4, 2022
Incidental Findings of Gallbladder and Bile Ducts-Management Strategies: General Aspects, Gallbladder Polyps and Gallbladder Wall Thickening-A World Federation of Ultrasound in Medicine and Biology (WFUMB) Position PaperChristian Jenssen, Torben Lorentzen, Christoph F Dietrich, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trialAnnika Berntsen, Redas Trepiakas, Lynn Wenandy, et al.BMJ Open|January 30, 2023
Randomised phase II trial of stereotactic body radiotherapy in combination with <b>check</b>point inhibitors in metastatic castration-resistant <b>pro</b>state cancer (CheckPRO): a study protocolNicklas Juel Spindler, Gitte Fredberg Persson, Susann Theile, et al.Cytotherapy|May 1, 2010
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trialRedas Trepiakas, Annika Berntsen, Sine Reker Hadrup, et al.BMC Cancer|March 6, 2022
High Intensity Aerobic exercise training and Immune cell Mobilization in patients with lung cancer (HI AIM)-a randomized controlled trialGitte Holmen Olofsson, Marta Kramer Mikkelsen, Anne-Mette Ragle, et al.European Journal of Cancer (Oxford, England : 1990)|January 2, 2023
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)Inna M Chen, Marco Donia, Christopher A Chamberlain, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2024
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 StudyAlice Markussen, Julia S Johansen, Finn O Larsen, et al.Pageof 3